ATLANTA, Georgia — Patients with atrial fibrillation receiving anticoagulant therapy are more likely to experience gastrointestinal (GI) bleeding when treated with rivaroxaban than when treated with ...
PHILADELPHIA — Gastrointestinal (GI) bleeding after percutaneous coronary intervention (PCI) among patients on dual antiplatelet therapy (DAPT) remains risky in terms of morbidity and mortality, but ...
Please provide your email address to receive an email when new articles are posted on . Rivaroxaban appeared associated with a higher rate of gastrointestinal bleeding than other direct oral ...
Gastrointestinal (GI) bleeding is a common and potentially life-threatening condition that requires prompt and accurate diagnosis. Esophagogastroduodenoscopy (EGD) and colonoscopy are the primary ...
Upper gastrointestinal (GI) bleeding refers to bleeding that occurs anywhere in the esophagus, the stomach, or the upper part of the small intestine. It is a symptom of an underlying disorder, and it ...
Researchers at Karolinska Institutet in Sweden have identified eight primary factors that increase the risk of a common bleeding complication after heart attack. Some of these factors are already ...
Gastrointestinal (GI) bleeding is bleeding in the digestive tract, anywhere from the throat to the rectum. A person can experience a small loss of blood, such as when a hemorrhoid bleeds, or a ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--EndoClot Plus, Inc. (EPI) announced the U.S. Food and Drug Administration (FDA) has approved EndoClot ® Polysaccharide Hemostatic System (EndoClot ® PHS), an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results